Home/ Shop/ Muscle & Performance/ TITAN 10 MG Peptide Blend

Muscle & Performance

TITAN 10 MG Peptide Blend

10MG BLEND: Ipamorelin 5MG · CJC No DAC 5MG

≥99% purity by HPLC
Janoshik COA with every lot
Lot-traceable from synthesis
EU-synthesised

In stock · Lot NZM-T-0026 · ships in 3–5 working days (EU)

Available for research procurement. Supplied as a lyophilized research compound with lot-specific COA.

Specifications

Lot NumberNZM-T-0026

Purity99.4% (HPLC)

Verified byJanoshik

Synthesis Date2026-04-12

FormLyophilized powder

StorageBelow 16°C · sealed

Third Party Lab Tested

Every lot is independently HPLC-tested by Janoshik Analytical, Europe's reference laboratory for peptide purity assessment. The COA shipped with your order is theirs, not ours.

Storage & Handling

Lyophilized peptides should be stored below 16°C, protected from light and moisture, for up to 24 months. Once reconstituted, refrigerate and use within 30 days for protocol consistency.

FormLyophilized powder

StorageLyophilized: below 16°C for up to 24 months. Reconstituted: refrigerate, use within 30 days.

Reconstitution

Reconstitute with bacteriostatic water using the volumes below. Add solvent slowly along the inside wall of the vial. Swirl gently, never shake, until fully dissolved.

Lab-handling protocol BAC Water · 0.9% benzyl alcohol The reconstitution solvent referenced above. Add to order →

Researched Benefits

Lean Mass Response Selective Ipamorelin's GHSR-1a selectivity isolates GH pulse without cortisol. Sleep Architecture Documented GH-pulse fidelity literature includes sleep-stage research. IGF-1 Modulation Pulsatile Physiological pulse pattern preserved. Selectivity Clean profile No measurable effect on cortisol, prolactin, aldosterone.

Product details

Two pathways. One defined blend.

TITAN is a defined 10 MG research blend containing Ipamorelin 5 MG and CJC-1295 no DAC 5 MG. Ipamorelin is studied as a selective ghrelin-receptor agonist, while CJC-1295 no DAC is a growth hormone-releasing hormone analogue. The paired composition supports comparison of two distinct secretagogue signalling pathways within one laboratory model.

The blend is supplied as a lyophilized research vial within the NZM-Labs peptide collection. Independent HPLC and mass-spectrometry analysis establishes purity, component identity and lot traceability for every production batch. For laboratory research only.

Compound Specs

Research specification table for TITAN 10 MG Peptide Blend
Compound 1	Ipamorelin · 5 MG
Molecular mass	711.86 Da
Mechanism / research class	Selective ghrelin-receptor agonist
Compound 2	CJC-1295 (no DAC) · 5 MG
Sequence length	30 amino acids
Molecular mass	3367.95 Da
Modeled half-life	~30 min
Mechanism / research class	GHRH analogue
Example laboratory preparation	10 MG blend vial with 2 mL bacteriostatic water (0.9% benzyl alcohol)
Calculated concentration	Ipamorelin 2.5 mg and CJC-1295 no DAC 2.5 mg per 1.0 mL
Supply format	TITAN · 10 MG blend lyophilized research vial
Storage, lyophilized	store below 16°C for up to 24 months
Storage, reconstituted	refrigerate and use within 30 days

Quality standards

Synthesised.
Verified.
Documented.

Wireframe rendering of a research peptide vial alongside molecular structure

Verified Purity

Every lot HPLC-tested by Janoshik Analytical. Independent verification, never in-house only. Current lot: 99.4% (HPLC).

Mass-Spec Confirmed

Identity confirmed by mass spectrometry. Theoretical mass matches measured within 0.5 Da tolerance.

Lyophilized & Sealed

Supplied as lyophilized powder in a sealed crimp-cap vial for laboratory handling and storage.

Lot-Traceable

From synthesis batch to your delivery, every step is logged. Search lot NZM-T-0026 for full traceability.

Evidence base

Backed by research.
Measured in results.

Each tag opens the cited literature behind that effect. References are linked to PubMed.

Selective

Lean Mass Response

TITAN combines Ipamorelin's selective ghrelin-receptor agonism with CJC-1295's GHRH amplification. The 1:1 mass ratio reproduces a physiological GH-pulse pattern, supporting research models studying lean mass response and recovery markers without engaging the cortisol / prolactin axes that broader GHRPs activate.

References

Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. PubMed ↗
Teichman SL et al. Prolonged stimulation of GH secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805. PubMed ↗

Documented

Sleep Architecture

Pulsatile GH release (vs sustained elevation) is associated with research findings on sleep-architecture endpoints. Selective GHSR-1a agonism preserves the natural pulsatile pattern that downstream IGF-1 systems are responsive to.

References

Copinschi G et al. Effects of growth hormone-releasing peptide on sleep. J Clin Endocrinol Metab. 1997;82(8):2776-2782. PubMed ↗

Pulsatile

IGF-1 Modulation

Combined ghrelin-receptor + GHRH-pathway engagement produces measurable increases in IGF-1 in research models with kinetics that follow the natural pulsatile envelope rather than a sustained-elevation profile.

References

Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sex Med Rev. 2018;6(1):45-53. PubMed ↗

Clean profile

Selectivity

The defining property of Ipamorelin in published literature is the selectivity of its GHSR-1a agonism. Unlike GHRP-2 or GHRP-6, no measurable effect on cortisol, prolactin, or aldosterone is reported - supporting cleaner research-protocol designs where pathway purity is the variable.

References

Raun K et al. Eur J Endocrinol. 1998;139(5):552-561. PubMed ↗

Specific to TITAN 10 MG Peptide Blend

Questions?
We have answers.

(01)

Why a 1:1 ratio of Ipamorelin to CJC?

The 1:1 ratio reflects the most-cited research protocols where Ipamorelin's selective ghrelin agonism is balanced against CJC-1295's GHRH amplification. Different ratios skew either toward more rapid pulse (more Ipamorelin) or longer release (more CJC). The 5+5 baseline is the most replicable starting point.

(02)

Why CJC No DAC instead of CJC with DAC?

DAC (Drug Affinity Complex) extends half-life by binding albumin, but it also produces sustained elevation rather than physiological pulses. Researchers studying GH-pulse fidelity prefer the no-DAC variant - it preserves the natural pulsatile pattern that downstream IGF-1 signaling depends on.

(03)

How is the Certificate of Analysis verified?

Every lot is sent to Janoshik Analytical for independent HPLC and mass spectrometry testing. The COA you receive is theirs, not ours - searchable by lot number at coa.nzmlab.com with no account required.

(04)

How is the product shipped?

Lyophilized vials are shipped across the EU. Store sealed vials below 16°C after delivery. Typical delivery takes 3–5 working days.

(05)

Is this a research product?

Yes. NZM peptides are sold strictly for in vitro and animal research use only. They are not for human consumption, off-label use, or clinical application. Please consult applicable local regulations before ordering.

(06)

What is the Titan research peptide price?

The current Titan price is shown on this page. Pricing applies to B2B research procurement only and may vary by lot, format, and availability.

(07)

Can research customers buy Titan from NZM-Labs?

Yes. Research customers can order Titan through NZM-Labs for in vitro and animal research use only. It is not sold for human consumption, clinical use, or self-administration.

Researcher reviews